OPY Acquisition Corp. I
OHAAW
NASDAQ Global Market0.00
USD
- -
- -
CIK
0001870778
ISIN
US6710051144
CUSIP
671005114
Return %
Stock
S&P500
1Y
- -
18.21
3Y
-96.50
64.38
5Y
-99.44
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Jonathan B. Siegel
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 85 Broad Street New York City NY United States of America 10004
- CIK
- 0001870778
- Similar Companies
- Business
- OPY Acquisition Corp. I operates as a blank check company whose shares trade under the ticker symbol OHAAW for warrants; the company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, with an initial focus on the life sciences industry including novel therapeutics, medical devices, and services that improve healthcare outcomes. Sponsored by Oppenheimer Alternative Investment Management LLC, an affiliate of Oppenheimer & Co. Inc., it targets assets primarily in the United States, Europe, and Israel, leveraging the management team's expertise in healthcare transactions. Incorporated in 2020 and headquartered at 85 Broad Street in New York, New York, the company raised $126.5 million through its initial public offering of units in October 2021, underwritten by Oppenheimer & Co. Inc. and Lake Street Capital Markets, with each unit comprising one Class A common share and one-half of a redeemable warrant exercisable at $11.50 per whole warrant. In December 2023, OPY Acquisition Corp. I announced its intent to dissolve and liquidate after failing to complete an initial business combination despite stockholder-approved extensions to June 2024 and an extensive target search amid challenging SPAC market conditions; public shares were redeemed pro rata from the trust account by December 28, 2023, with trading suspended and Nasdaq delisting via Form 25, followed by SEC registration termination via Form 15.